-- グロービング（TYO:277A）は、同取引所のグロース市場からプライム市場へ上場市場を移行する。
同社は、この転換後も引き続き事業の拡大に注力していくと述べた。
Related Articles
Asia
GCL Technology Unit to Raise $148 Million via Debt Offering
GCL Technology (HKG:3800) said its GCL Solar Star Investment unit plans to raise $148 million via a debt offering, according to a Hong Kong bourse filing Wednesday.The solar materials manufacturer's shares were down over 4% in late morning trade Thursday.The issue involves the sale of 6.95% guaranteed convertible bonds due 2027 that can be exchanged for shares of GCL Technology at an initial rate of HK$1.21 per conversion share.Assuming full conversion, the bonds would net 958.6 million GCL Technology shares, representing 2.80% of the business on an enlarged basis.The convertible bonds are planned for listing in Vienna.Proceeds from the debt offering will be used for general corporate purposes and repayment of debts, GCL Technology said.
$HKG:3800
Asia
Ramelius Resources on Track to Achieve Midpoint of Fiscal Year 2026 Production Guidance, Euroz Hartleys Says
Ramelius Resources (ASX:RMS) might be able to achieve the midpoint of its fiscal year 2026 production guidance due to stockpiles at its Dalgaranga and Penny gold operations, Euroz Hartleys said in a Wednesday note.The company released its March quarter report, with production falling from the previous quarter due to haul road closures and heavy rainfall. It maintained fiscal year 2026 production guidance at 185,000 to 205,000 ounces.Euroz Hartleys forecasts June quarter production of roughly 55,000 ounces at an all-in sustaining cost of around AU$2,200 per ounce."We remain excited for the ramp up of Dalgaranga with first ore one month ahead of schedule," the equity research firm said, adding that a ball mill drive train upgrade will allow a finer grind for the Dalgaranga ore, improving recoveries to above 90% from around 80%. It also pointed to an opportunity for Ramelius Resources to displace low-grade stockpiles with higher-grade mined ore from fiscal year 2028 to fiscal year 2030.Euroz Hartleys maintained a buy recommendation on Ramelius Resources and lowered its price target to AU$5.27 per share from AU$6.21, mainly due to a lower spot gold price.Shares of Ramelius fell 5% in recent Thursday trade.
$ASX:RMS
Asia
Mesoblast Says Nearly $100 Million in Revenue Generated During First Year of Ryoncil Launch; Shares Fall 5%
Mesoblast (ASX:MSB) said gross sales for Ryoncil, its mesenchymal stromal cell product, during the March quarter were $35.3 million, according to a Thursday Australian bourse filing.Net revenue was $30.3 million, bringing the revenue generated during the first year of the product's launch to nearly $100 million, per the filing.Receipts from customers were $34.6 million in the March quarter, compared with $1.5 million in the year-ago period.Mesoblast's shares fell nearly 5% in recent trading on Thursday.
$ASX:MSB